PPD Selected as Exclusive Partner by DiabetesAmerica
Wilmington, NC
PPD, Inc. announced it has entered into an exclusive alliance with DiabetesAmerica, a provider of comprehensive diabetes care services based in Houston, Texas. Under the agreement, PPD will provide clinical research training and support to more than 20 clinical trial investigators who will conduct Type 1 and Type 2 diabetes clinical trials from DiabetesAmerica's 17 centers across Texas and Arizona.
In return, DiabetesAmerica will work exclusively with PPD to provide clinical research services for endocrine and metabolic disease development programs over a minimum of three years. The agreement expands PPD's ability to recruit for diabetes-related clinical trials through the use of DiabetesAmerica's 16,000-plus patient database.
"Diabetes is a disease with serious complications that affects more than 23 million Americans," said Mike Wilkinson, executive vice president of clinical development at PPD. "We are pleased to assist these physicians in bringing cutting-edge diabetes treatments to their patients through training and support. In addition, DiabetesAmerica's patient database expands our ability to offer clinical trial options to a broader population of people living with this increasingly common disease."
"DiabetesAmerica is committed to delivering the latest treatments in diabetes care to our patients," said Rosemary Mazanet, MD, PhD, and CEO of DiabetesAmerica. "Our alliance with PPD will help ensure our physicians are fully trained on managing drug development programs so we can continue to bring complete diabetes care to our patients."
See a free diabetes and obesity podcast series to learn more about clinical trials in these therapeutic areas.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
